{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:55:35Z","timestamp":1776833735949,"version":"3.51.2"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,26]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Erdheim-Chester disease (ECD) is a rare multisystemic disease characterized by the infiltration of multiple organs by foamy CD68\u2005+\u2005CD1a-histiocytes. The genetic background consists of gain-of-function somatic mutations in the mitogen-activated protein kinase pathway. The purpose of the present paper is to make a contribution to the scientific literature on ECD by reporting our experience with a complex clinical case report, along with a concise review of the literature. We discussed the unusual clinical presentation, the complex diagnostic process and the comparison with other published cases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 70-year-old man presented with arthralgia due to multiple bone areas of sclerosis, first diagnosed with metastases of a prostatic neoplasm. Sequential thorax-abdomen, femoral and homer contrast-enhanced computed tomography (CT) showed pericardial effusion, pulmonary fibrosis, and perirenal fibrous tissue as \u201chairy kidneys.\u201d He underwent. Three bone biopsies were unsuccessful to reach diagnosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>A xanthelasma biopsy showed histopathological signs compatible with ECD; genetic analysis showed the mutation BRAFV600E.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient underwent targeted therapy with vemurafenib (BRAF-inhibitor), discontinued 2 weeks later due to the onset of a diffuse erythematous papular rash on the trunk and limbs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>At the 1-year follow-up, there was only progression of chronic kidney disease (CKD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>The present case report describes how ECD diagnosis could represent a challenge for clinicians, owing to its heterogeneous clinical presentation. Early diagnosis followed by prompt therapy is essential for modifying the natural history of the disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000037870","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T18:13:57Z","timestamp":1714155237000},"page":"e37870","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Erdheim-Chester disease as complex clinical presentation and diagnosis: A case report and concise review of literature"],"prefix":"10.1097","volume":"103","author":[{"given":"Carola M.","family":"Gagliardo","sequence":"first","affiliation":[{"name":"Department of Health Promotion, Maternal and Child Health, Internal and Specialized Medicine of Excellence \u201cG. D. Alessandro\u201d (PROMISE), University of Palermo, Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonina","family":"Giammanco","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Maternal and Child Health, Internal and Specialized Medicine of Excellence \u201cG. D. Alessandro\u201d (PROMISE), University of Palermo, Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto","family":"Vaglio","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, Meyer Children\u2019s Hospital IRCCS, Florence, Italy"},{"name":"Department of Biomedical, Experimental and Clinical Sciences \u201cMario Serio,\u201d University of Florence, Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Pegoraro","sequence":"additional","affiliation":[{"name":"Department of Health Science, University of Florence, Florence, Italy"},{"name":"Pediatric Hematology and Oncology Unit, Meyer Children\u2019s University Hospital IRCCS, Florence, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo B.","family":"Cefal\u00f9","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Maternal and Child Health, Internal and Specialized Medicine of Excellence \u201cG. D. Alessandro\u201d (PROMISE), University of Palermo, Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Averna","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Maternal and Child Health, Internal and Specialized Medicine of Excellence \u201cG. D. Alessandro\u201d (PROMISE), University of Palermo, Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5346-2829","authenticated-orcid":false,"given":"Davide","family":"Noto","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Maternal and Child Health, Internal and Specialized Medicine of Excellence \u201cG. D. Alessandro\u201d (PROMISE), University of Palermo, Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","article-title":"Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.","volume":"127","author":"Emile","year":"2016","journal-title":"Blood"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1182\/blood.2019002766","article-title":"Erdheim-Chester disease.","volume":"135","author":"Haroche","year":"2020","journal-title":"Blood"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11926-019-0865-2","article-title":"Erdheim-Chester disease: a concise review.","volume":"21","author":"Papo","year":"2019","journal-title":"Curr Rheumatol Rep"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1038\/s41375-020-0944-4","article-title":"Erdheim-Chester disease: a rapidly evolving disease model.","volume":"34","author":"Pegoraro","year":"2020","journal-title":"Leukemia"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","article-title":"Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis.","volume":"35","author":"Sun","year":"2015","journal-title":"J Recept Signal Transduct Res"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"434","DOI":"10.48095\/ccko2021434","article-title":"Erdheim-Chester disease.","volume":"34","author":"Brychtov\u00e1","year":"2021","journal-title":"Klin Onkol"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jaccao.2020.03.004","article-title":"Cardiac tamponade as the first manifestation of Erdheim-Chester disease.","volume":"2","author":"Costa","year":"2020","journal-title":"JACC CardioOncol"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.mayocp.2019.02.023","article-title":"The Mayo Clinic Histiocytosis Working Group consensus statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms: Erdheim-Chester disease, Langerhans cell histiocytosis, and Rosai-Dorfman disease.","volume":"94","author":"Goyal","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.joms.2021.01.009","article-title":"Oral findings of Erdheim-Chester disease: a case report and review of the literature.","volume":"79","author":"Sorenson","year":"2021","journal-title":"J Oral Maxillofac Surg"},{"key":"R11-20250503","first-page":"gin\/33.6.11","article-title":"The Ormond\u2019s disease: an intriguing obstructive nephrouropathy.","volume":"33","author":"Manganelli","year":"2020","journal-title":"G Ital Nefrol"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(06)68035-5","article-title":"Retroperitoneal fibrosis.","volume":"367","author":"Vaglio","year":"2006","journal-title":"Lancet"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2214\/ajr.183.5.1831253","article-title":"Imaging of thoracoabdominal involvement in Erdheim-Chester disease.","volume":"183","author":"Dion","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.kint.2022.09.027","article-title":"Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosis.","volume":"103","author":"Chazal","year":"2010","journal-title":"Kidney Int"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00415-006-0160-9","article-title":"Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature.","volume":"253","author":"Lachenal","year":"2006","journal-title":"J Neurol"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/B978-0-12-820683-6.00010-5","article-title":"Neuroendocrine manifestations of Erdheim-Chester disease.","volume":"181","author":"Manaka","year":"2021","journal-title":"Handb Clin Neurol"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"ytab351","DOI":"10.1093\/ehjcr\/ytab351","article-title":"Erdheim-Chester disease presenting as an intracardiac mass and pericardial effusion confirmed by biopsy: a case report.","volume":"5","author":"Yoon","year":"2021","journal-title":"Eur Heart J Case Rep"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","article-title":"Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.","volume":"124","author":"Diamond","year":"2014","journal-title":"Blood"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jaad.2015.11.007","article-title":"Cutaneous manifestations of Erdheim-Chester disease (ECD): clinical, pathological, and molecular features in a monocentric series of 40 patients.","volume":"74","author":"Chasset","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood-2017-03-771873","article-title":"Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study).","volume":"130","author":"Cohen Aubart","year":"2017","journal-title":"Blood"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"101510","DOI":"10.1016\/j.berh.2020.101510","article-title":"Erdheim-Chester disease.","volume":"34","author":"Starkebaum","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamaoncol.2017.5029","article-title":"Vemurafenib for BRAF V600-Mutant Erdheim-Chester disease and langerhans cell histiocytosis: analysis of data from the histology-independent, phase 2, open-label VE-BASKET study.","volume":"4","author":"Diamond","year":"2018","journal-title":"JAMA Oncol"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/bjh.14284","article-title":"Efficacy of the MEK inhibitor cobimetinib for wild-type BRAF Erdheim-Chester disease.","volume":"180","author":"Cohen Aubart","year":"2018","journal-title":"Br J Haematol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037870","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:41:58Z","timestamp":1746319318000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":22,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037870","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,26]]}}}